Navigation Links
Patent Attorney John Rizvi Speaks at FIME International Medical Expo

The FIME 2009 International Medical Expo is the largest and most comprehensive medical exposition of its kind. John Rizvi will deliver a presentation titled, "Preservation of Legal Rights in Medical Innovations" at the FIME 2009 International Medical Expo in Miami Beach.

Miami, FL (PRWEB) August 5, 2009 -- On August 13, 2009 at 1:00 PM, attorney John Rizvi will deliver a presentation titled, "Preservation of Legal Rights in Medical Innovations" at the FIME 2009 International Medical Expo in Miami Beach.

Florida has one of the country's largest medical device sectors. Florida ranks second in the U.S. for number of FDA-registered medical device establishments, according to the FDA (2007). Over 20,000 Floridians work in this sector.

The FIME 2009 International Medical Expo is the largest and most comprehensive medical exposition of its kind. The exposition will feature medical manufacturers from around the world. It is held at the Miami Beach Convention Center, with over 500,000 square feet of exhibitor space. The four types of featured attendees are medical equipment, medical products, medical services and medical technology companies.

South Florida has seen steady growth in the medical device industry over the past ten years and John Rizvi, a patent attorney who specializes in patenting medical devices, is giving a presentation to educate medical technology companies on the importance of patenting new inventions.

"Patents help eliminate competition by giving patent holders the right to prevent anyone else from making, using, selling, or importing competing products in their market. This allows a patent holder to maintain monopoly pricing and avoids the product becoming a commodity," said Rizvi.

Patents for medical device companies have become increasingly important as more competitors from overseas and nationally are launching knock-off products based on a patent holder's intellectual property.

John Rizvi said that he often sees companies work with attorneys who don't fully understand the medical patent industry and draft claims that are too narrow in scope. This can allow a competitor to "design around" a patented product.

John Rizvi has over 14 years of experience focused exclusively on the preparation and prosecution of U.S. and international patent and trademark applications, patent and trademark validity and infringement opinions, licensing, transactional support, and all aspects of intellectual property litigation. John is an Adjunct Professor at the Nova Southeastern University Shepard Board Law Center where he teaches courses in intellectual property law.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
5. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
8. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
Post Your Comments:
(Date:11/30/2015)... Dec. 1, 2015  An interventional radiology technique shows promise ... preliminary results of a study being presented today at the ... America (RSNA). --> ... decades by interventional radiologists as a way to stop bleeding ... as a means of treating obesity is new. ...
(Date:11/30/2015)... /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") today ... to its Board of Directors to replace Dr. ... wealth of experience as co-founder of Resverlogix, with expertise in ... --> --> Dr. Wong remarked, "I am ... Zenith,s long standing expertise in epigenetics and the advanced stage ...
(Date:11/30/2015)... TapImmune, Inc. (TPIV), a ... peptide and gene-based immunotherapeutics and vaccines for the treatment ... be presenting at the 8 th Annual LD ... PM PT. Dr. John N. Bonfiglio a ... the presentation and will join TapImmune management in meeting ...
(Date:11/30/2015)...  Northwest Biotherapeutics (NASDAQ: NWBO ) ("NW Bio"), ... for solid tumor cancers, announced today that the Board ... the Company welcomes Neil Woodford,s call for ... internet report on NW Bio.  The Company,s Board is ... stated, "We agree with Mr. Woodford that, at ...
Breaking Biology Technology:
(Date:11/4/2015)... York , November 4, 2015 ... a new market report published by Transparency Market Research "Home ... Growth, Trends and Forecast 2015 - 2022", the global home ... US$ 30.3 bn by 2022. The market is estimated ... forecast period from 2015 to 2022. Rising security needs ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
(Date:10/29/2015)... BOSTON , Oct. 29, 2015  Connected health ... phenomena driving the explosion of technology-enabled health and wellness, ... his new book, The Internet of Healthy ... apps, sensors or smartphones even existed, Dr. Kvedar, vice ... model of health care delivery, moving care from the ...
Breaking Biology News(10 mins):